| 2023 | Validation of the simplified magnetic resonance index of activity by using DWI without gadolinium enhancement to evaluate bowel inflammation in Crohn's disease | EUROPEAN RADIOLOGY |
| 2023 | Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer | CANCER GENE THERAPY |
| 2023 | Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet's disease
| ARTHRITIS RESEARCH & THERAPY |
| 2023 | Long-term clinical outcomes of intestinal Behçet's disease: A 30-year cohort study at a tertiary hospital in South Korea | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | TRIM40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integrity
| NATURE COMMUNICATIONS |
| 2023 | Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
| YONSEI MEDICAL JOURNAL |
| 2023 | Past, present, and future of Intestinal Research
| INTESTINAL RESEARCH |
| 2023 | Factors associated with the prescription of probiotics in patients with inflammatory bowel disease: a cross-sectional study
| Journal of Yeungnam Medical Science |
| 2023 | Comparing the efficacy of different methods of faecal microbiota transplantation via oral capsule, oesophagogastroduodenoscopy, colonoscopy, or gastric tube | JOURNAL OF HOSPITAL INFECTION |
| 2023 | The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
| INTESTINAL RESEARCH |
| 2022 | Corticosteroids and Mesalamine Versus Corticosteroids for Acute Severe Ulcerative Colitis: A Randomized Controlled Trial | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2022 | Aminoclay Nanoparticles Induce Anti-Inflammatory Dendritic Cells to Attenuate LPS-Elicited Pro-Inflammatory Immune Responses
| MOLECULES |
| 2022 | Clinical Characteristics of Korean Patients with Elderly-Onset Crohn's Disease: Results from the Prospective CONNECT Study
| GUT AND LIVER |
| 2022 | Microbial Modulation in Inflammatory Bowel Diseases
| IMMUNE NETWORK |
| 2022 | Clinical Features and Long-term Prognosis of Crohn's Disease in Korea: Results from the Prospective CONNECT Study
| GUT AND LIVER |
| 2022 | Improvement in Medication Adherence after Pharmacist Intervention Is Associated with Favorable Clinical Outcomes in Patients with Ulcerative Colitis
| GUT AND LIVER |
| 2022 | Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2022 | Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn's Disease Comparing, between CT-P13 and Originator Infliximab
| GUT AND LIVER |
| 2022 | Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
| GUT AND LIVER |
| 2022 | Application of Multigene Panel Testing in Patients With High Risk for Hereditary Colorectal Cancer: A Descriptive Report Focused on Genotype-Phenotype Correlation | DISEASES OF THE COLON & RECTUM |
| 2022 | Tumor-Suppressive Effect of Metformin via the Regulation of M2 Macrophages and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment of Colorectal Cancer
| CANCERS |
| 2022 | A GLP-1/GLP-2 receptor dual agonist to treat NASH: Targeting the gut-liver axis and microbiome | HEPATOLOGY |
| 2022 | Smad4 and p53 synergize in suppressing autochthonous intestinal cancer
| CANCER MEDICINE |
| 2022 | Efficient gene transfection to lung cancer cells via Folate-PEI-Sorbitol gene transporter
| PLOS ONE |
| 2022 | Radiology plus ileocolonoscopy versus radiology alone in Crohn’s disease: prognosis prediction and mutual agreement
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2022 | Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn's Disease Recurrence
| GUT AND LIVER |
| 2022 | Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function
| FRONTIERS IN IMMUNOLOGY |
| 2022 | Rebleeding Rate and Risk Factors for Rebleeding after Device-Assisted Enteroscopy in Patients with Obscure Gastrointestinal Bleeding: A KASID Multicenter Study
| DIAGNOSTICS |
| 2022 | Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients with inflammatory bowel diseases
| SCIENTIFIC REPORTS |
| 2022 | Comparative effectiveness of second-line biological therapies for ulcerative colitis and Crohn's disease in patients with prior failure of anti-tumour necrosis factor treatment
| BMC GASTROENTEROLOGY |
| 2022 | Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
| BMJ OPEN GASTROENTEROLOGY |
| 2022 | Impact of Visceral Fat on Survival and Metastasis of Stage III Colorectal Cancer
| GUT AND LIVER |
| 2022 | Faecal microbiota transplantation reduces amounts of antibiotic resistance genes in patients with multidrug-resistant organisms
| ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL |
| 2021 | Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis
| GUT AND LIVER |
| 2021 | Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model | INTESTINAL RESEARCH |
| 2021 | C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet's disease
| BMC GASTROENTEROLOGY |
| 2021 | An Escherichia coli strain with extra catalase activity protects against murine colitis by scavenging hydrogen peroxide and regulating regulatory t cell/interleukin-17 pathways | FREE RADICAL BIOLOGY AND MEDICINE |
| 2021 | Behçet syndrome | NATURE REVIEWS DISEASE PRIMERS |
| 2021 | Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2021 | Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?
| GUT AND LIVER |
| 2021 | Efficacy and tolerability of infliximab retreatment in patients with inflammatory bowel disease: a systematic review and meta-analysis
| THERAPEUTIC ADVANCES IN CHRONIC DISEASE |
| 2021 | Early course of newly diagnosed moderate-to-severe ulcerative colitis in Korea: Results from a hospital-based inception cohort study (MOSAIK) | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | Infliximab Biosimilar CT-P13 Observational Studies for Rheumatoid Arthritis, Inflammatory Bowel Diseases, and Ankylosing Spondylitis: Pooled Analysis of Long-Term Safety and Effectiveness | ADVANCES IN THERAPY |
| 2021 | A transepithelial pathway delivers succinate to macrophages, thus perpetuating their pro-inflammatory metabolic state
| CELL REPORTS |
| 2021 | Deep-learning system for real-time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2021 | The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study
| THERAPEUTIC ADVANCES IN GASTROENTEROLOGY |
| 2021 | Succinate-treated macrophages attenuate dextran sodium sulfate colitis in mice
| INTESTINAL RESEARCH |
| 2021 | Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View
| YONSEI MEDICAL JOURNAL |
| 2021 | Physical activity and quality of life of patients with inflammatory bowel disease
| MEDICINE |
| 2021 | Proteomic analysis-based discovery of a novel biomarker that differentiates intestinal Behçet's disease from Crohn's disease
| SCIENTIFIC REPORTS |
http://orcid.org/0000-0002-2282-8904
(35200350500)
